chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Woke up at 3 am; Night sweats; Stomach pain; Threw up 3 times which made my stomach feel much better; Sat on toilet was only able to pass gas; laid flat on back on floor sweating with not enough energy to get back in bed for 10 minutes; Laid in bed under blankets cold and shivering; Broke out in fever; Laid in bed under blankets cold and shivering; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 21 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Sep2021 10:45 (Lot number: EW 0164) at the age of 21 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Covid-19" (unspecified if ongoing), notes: prior to the vaccination the patient was diagnosed with Covid-19. Concomitant medication(s) included: VYVANSE. Vaccination history included: Bnt162b2 (Dose 1, lot number: FC 3181,, Administration date 17Aug2021,, Administration time 03:00 PM,, vaccine location: Left Arm), administration date: 17Aug2021, when the patient was 21 years old, for Covid-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 29Sep2021 23:00, outcome "recovering", described as "Broke out in fever"; FEELING COLD (non-serious), CHILLS (non-serious) all with onset 29Sep2021 23:00, outcome "recovering" and all described as "Laid in bed under blankets cold and shivering"; TERMINAL INSOMNIA (non-serious) with onset 30Sep2021 03:00, outcome "recovering", described as "Woke up at 3 am"; NIGHT SWEATS (non-serious) with onset 30Sep2021 03:00, outcome "recovering", described as "Night sweats"; ABDOMINAL PAIN UPPER (non-serious) with onset 30Sep2021 03:00, outcome "recovering", described as "Stomach pain"; VOMITING (non-serious) with onset 30Sep2021, outcome "recovering", described as "Threw up 3 times which made my stomach feel much better"; FLATULENCE (non-serious) with onset 30Sep2021, outcome "recovering", described as "Sat on toilet was only able to pass gas"; ASTHENIA (non-serious) with onset 30Sep2021, outcome "recovering", described as "laid flat on back on floor sweating with not enough energy to get back in bed for 10 minutes". Therapeutic measures were taken as a result of pyrexia. Therapeutic measures were not taken as a result of feeling cold, terminal insomnia, chills, night sweats, abdominal pain upper, vomiting, flatulence, asthenia.  Additional Information: Patient took Dayquil to help with fever. Patient further reported that, once he woke up at 3:00 AM he again got back in bed and fell asleep till the fire alarm in his apartment went off at 5am and had to stand outside for 30 minutes.  Felt like a low fever at this point.  Went back to bed until 1:30pm and have had low amount of energy all day. It was sated that hospitalization prolonged as No. It was reported that, the patient was not tested for Covid-19 since the vaccination.  No follow-up attempts are possible. No further information is expected.
10:03  voice hoarse, heartbeast fast    B/P 160/86  Pulse 99    O2 sat 97% 10:06 still hoarse,     B/P 150/90    Pulse 90     O2 sat 97%    took sip water 10:15  voice normal   B/P 140/89   Pulse 78   )2 sat 98% 10:18 Recovered and sent home with husband
Sudden onset chills (patient described as seizure like) and high fever. Lasted overnight for about 10 hours. Was gone the next day. No treatment used.
The questions were about headache, etc.  I had these symptoms at some point after my vaccine, but not immediately after.  I think the "adverse event(s)" were unrelated to the vaccine since those conditions had occurred prior to any vaccine as well (that question wasn't asked).
Right after the vaccine, I had a very swollen lymph node under my left armpit and I was tired and I had a few chills. Those symptoms lasted about two days. Recent infection - On Monday, the 28th of June, I started noticing I was feeling off. The first three days, I was just very tired. But we had just traveled and I wrote it off as exhaustion from trip. After that, I developed a scratchy throat and congestion. That developed into a sore throat. Once I got a sore throat, July 4,  I went to  Clinic Urgent Care -   Health System and they tested for COVID and Strep.  The back of my throat looked consistent to drainage. The drainage was causing cobble stoning in my throat. She prescribed "Magic Mouthwash" - swish for sore throat - used it for two days. I also started taking Mucinex and Sudafed for the congestion and that's when it started coming out. And I day after that, the sore throat went away but I got congestion - severe congestion and coughing up drainage. And that lasted for about four days and it finally now has worked it's way out. There's a tiny bit of it left but it's mostly gone.
chest pain Narrative: 6yo man received first dose Pfizer Covid vaccine on 3/1/21. Patient subsequently presented to the ED on 3/13/21 with a one day history of atypical chest pain and shortness of breath with walking and lying down. It is very unlikely that the vaccine is related to the patient's episode of chest pain. From a vaccination standpoint, it is safe for the patient to receive his second COVID vaccine as scheduled.
Loss of vision Started on 05/26/2021 and dizziness on 05/27/2021, was admitted to hospital from 05/27/2021 to 05/31/2021. The dizziness was treated during hospital stay but vision was declining. Went to see eye doctor but no problem was found in eyes. Till 06/04/2021 left eye was completely blind and red eye can only see light coming through but wasn't able to walk independently. Went back to hospital and admitted from June 4th to June 20th 2021. During this stay, Patient was diagnosed with Neuromyelitis optica and treated by steroids, plasmapheresis and Rituximab.
Patient received vaccine on 11/4/2019 at 8:30 am.  Patient reported to RN that she began vomiting on 11/4/2019 pm.  Patient vomited x 3 days. Patient reported that a rash "hives" appeared on face on 11/5/2019 that resolved on 11/6/2019.   Patient reported no fever.  {Patient reported mild swelling at injection site.
pt recvd vax 27sep94;6 & 7 days later,exhibited 3 episodes of tremors; each episode lasted about 10 secs & affected upper body, especially arms, hands & face;babysitter describe similar episode occuring 4oct approx 7pm;
Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 72-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 08-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported No Treatment medications were reported
The patient came in to receive his second pfizer dose.  His paperwork was mixed in with some Moderna shots and he inadvertently received Moderna as a second dose instead of pfizer.  There has not been any adverse events from this, and according to the CDC, it is okay to receive a different mRNA vaccine as a second dose in certain situations.
Patient awoke at 6:20 a.m. with labored breathing, pruritis, red face, facial pain and swelling of lips.  Mother states she also had headache and described a blotchy skin rash on both arms.  The mother gave her acetaminophen and brought her to the emergency department.  Patient states that symptoms improved significantly after acetaminophen although she still had a mild headache and itching.  In the emergency department no facial swelling or rash was observed.  The oropharynx was clear without erythema or exudate.  There was no stridor or trismus.  She was given a dose of diphenhydramine.  The mother was told to give diphenhydramine, acetaminophen and ibuprofen as needed and the patient was dischanged.
Contracted cellulitis within hours of receiving flu shot. Extremely sick almost hospitalized. I was on antibiotics for 14 days.
TIA; This is a spontaneous report received from non-contactable reporter (Consumer) from a sales representative. An adult female patient received NT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. It was reported that the patient received a dose of Pfizer BioNTech Covid 19 vaccine and within a short timeframe (minutes) had a TIA (Transient ischaemic attack). It was reported that the patient had numbness in her face. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
About 9 hours after the vaccination, welt/bumps broken out on the left side of forehead, above temple and under hairline.  They looked like milk duds, sizes varied but two were much larger than the other two.  The size reduced after taking Pepsid but returned the next morning and are still there.  Took Pepsid again and the size reduced but are still present.
woke up at 4am with xtreme chills.  2 blankets.  back to sleep.  All morning feels like a horrible hangover - aches, slight dizziness, incapacitation, etc.
Patient accidentally received a full dose of Moderna instead of a booster dose.  Her first vaccine was a J and J so this should have been a booster dose to complete the series but was given a full dose.  No adverse effect.
Arm rash, itchiness, redness, hard knot at injection site. No fever.
Patient presented to emergency room with chief complaint of chest pain. MI ruled out diagnosis of myocarditis associated with smallpox vaccination 2/5/03. Patient was initially admitted to cardiac ICU, but then discharged to home in stable condition on 2/16/03. Echo normal. Patient will be followed up in 2 weeks by doctor.
Information has been received from a physician and a practice manager via two company representatives referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant medication were unknown. On 06-JAN-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5 ml (lot # L010598, expiration date 06-AUG-2016, route unknown). This specified lot number vaccine was exposed to temperature excursion fifteen times. The total cumulative excursion time (hour) and lowest recorded temperature (Fahrenheit degree) for each time were as below: (216, 29.3); (144, 34.2); (24, 33.6); (24, 33.4); (52, 33.1); (72, 32.9); (144, 32.4); (100, 34.5); (28, 30); (24, 34.3); (104, 29.1); (48, 34.9); (36, 31.1); (40, 34); (24, 34.8). The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Severe inflammation of arthritis in right knee joint and surrounding areas/tissues, including Baker's Cyst. Physical therapy sessions (6) since then has helped, but I have not reached total pain resolution yet.
Was released from the testing site 5-10 minutes after second dose was administered. Approximately 15-20 minutes after dose was administered I began feeling a reaction. The skin on my face, neck, and chest became red, flushed, warm, splotchy, and itchy. My tongue and throat began to feel swollen/tight. I was also lightheaded and dizzy. My husband was driving the car and we almost returned to the vaccination site, but after approximately 5 more minutes, the tightness in my throat subsided, so we continued to go home. The flushing and lightheaded-ness went away after approximately 20 minutes. This is similar to the reactions I had just before I discontinued taking copaxone (approx. 2 years ago). I did not feel this way after dose one of the Pfizer COVID vaccine.
Delayed localized hypersensitivity to injection site (Covid Vaccine Arm) to right arm: rash, intense itching, pain, redness, sensitive to touch, sore upper arm
Pt recvd vax & exp urticarial rash; treatment Pred, topical steroid; MD reporter indicates that as time has progressed pt has intermittently cleared & very unsure if indeed did react to Engerix-B;
Subsequent to receiving vax, the pt experienced bloodshot eyes. Follow up information was received 01/29/2001 from the original reporting nurse that indicated that the patient received Flu Shield (2000-2001 Formula) on an unspecified date. No adverse events or bloodshot eyes resulted.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 23-APR-2013 the patient was inadvertently vaccinated with an expired PEDVAXHIB (dose 0.5 ml, intramuscular route) (lot number 0437AA) vaccine that has expired on 09-APR-2013. No concomitant medications were reported. No adverse effects reported. This case is linked to MARRS 1304USA015547 and 1305USA000265. Additional information has been requested.
Information has been received from a physician's assistant concerning an 88 year old male patient with hypertension, hyperlipidemia, arthritis, aortic valve disease and strawberries allergy who on 14-Febuary-2008, was vaccinated with a dose of ZOSTAVAX (Merck) 0.65ml subcutaneously. Concomitant therapy included Coumadin, Simvastatin (MSD), Celebrex, Lasix and Hydrocodone. The physician's assistant reported that in the morning of 20-May-2009, the patient developed on his right thigh what looked like shingles. The patient was seen on the physician's office and was placed on VALTREX. At the time of the report, the patient had not recovered. The patient was enrolled in the Varicella Zoster Identification program to identify if VZV is present and if it is present to identify if it is associated with wild-type VZV strain or with the OKA/Merck vaccine VZV strain. The sample of the lesion was collected on 20-May-2009. Additional information has been requested.
I have had cramps before, but after the vacine cramps were more frequent and severe. I am a runner and before the vaccination the cramps where usually after a long run due too desihadration.  After theModerna 2nd. dose the cramps ocured any time unespected and severe. This lasted for about one month and a half. I do not have this severe cramps since.
This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 78-year-old female patient who received SHINGRIX (batch number N72HZ, expiry date 9th June 2021) for prophylaxis. Concurrent medical conditions included breast cancer (diagnosed 4 months before the date of reporting) and lumpectomy (diagnosed left side or left breast lumpectomy 3 months before the date of reporting). On 27th March 2019, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 31st March 2019, 4 days after receiving SHINGRIX, the patient experienced fever (serious criteria hospitalization), breast enlargement (serious criteria hospitalization), breast swelling (serious criteria hospitalization) and breast induration (serious criteria hospitalization). The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the fever was unknown and the outcome of the breast enlargement, breast swelling and breast induration were not recovered/not resolved. It was unknown if the reporter considered the fever, breast enlargement, breast swelling and breast induration to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in the left deltoid. The SHINGRIX batch number was updated from N72H2 to N72HZ as per sales data sheet. On 31st March 2019, the patient was admitted to the emergency room with mild fever, swollen, enlarged, hard left breast. It was reported that there was nothing to drain at that time. It was unknown if the patient was hospitalized overnight or not. The patient was receiving Tylenol to manage mild fever. The reporter did not consent to follow up.
Site: Pain at Injection Site-Mild, Additional Details: Patient suffered no immediate adverse reaction to the vaccine.  However, her Perigard IUD failed a couple of days after receiving her first dose of the Moderna covid shot, resulting in pregnancy.  This may be purely coincidental.  And IUD has since been removed.  Upon inspection, IUD has no apparent damage or no migration after insertion that would result in its failure.
Tinnitus started the day after the vaccination. It is constant, but some days are worse than others. On the bad days, it is accompanied by extreme dizziness.
Heaviness in chest within 30 mins of shot  Headache starting two hours after shot  Within 24 hours: fever, aches, weakness, tired, along with headache .  Treatment: rest and Tylenol.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 08-FEB-2017, the patient was vaccinated with an improperly stored dose of M-M-R II lot # M016234, expiration date 31-MAR-2018 (dose and route of administration were not provided) for prophylaxis. There were no adverse effects reported. Administered dose of M-M-R II was exposed to a temperature excursion of >8°C but <25°C (>46°F but <77°F) for 10 hours. Data logger was involved. There were previous excursions reported as follows: >8°C but <25°C (>46°F but <77°F) for 10 hours. This is one of several reports received from the same source. Additional information has been requested. Sender's Comments: US-009507513-1702USA007980: US-009507513-1703USA002298: US-009507513-1703USA002299.
This spontaneous report was received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. Concurrent conditions, medical history and allergies were not reported. On an unknown dates, an unspecified number of patients were vaccinated with unknown number of doses of (Oka/Merck) VARIVAX, (strength, dose, route, anatomical location, lot number and expiration date were not reported) which were improperly stored. No adverse effects were reported and no product quality complaint (PQC) was involved. Follow up information was receiving from a certified medical assistant during a phone call on 25-MAR-2015. The certified medical assistant was unavailable at the time of the call. The call was transferred to the manger who indicated that the (Oka/Merck) VARIVAX lot # was H018758 with expiration date: 11-OCT-2014 (also reported as 31-JAN-2015) and indicated that the patient identification information was not readily available at the time of the call. Additionally, the reporter indicated that there had been no reports of adverse events following the administration of (Oka/Merck) VARIVAX vaccinations. The office was in the process of contacting the patients for revaccination. The correspondence process was reviewed and telephone number was provided should information become available. This is one of several reports received from the same reporter. Additional information has been requested.
sore arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Tetanus with an associated reaction of pain in extremity (had sore arm like a tetanus shot).   On 3rd October 2019, the patient received the 1st dose of Shingrix. On 3rd October 2019, less than a day after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not provided. The age group of the patient was not reported, but selected as an adult as per vaccine indication. After vaccination with dose of Shingrix, the patient had sore arm like a tetanus shot. The patient wanted to know the average time for those who do get side effects. The patient did not contact to physician for the sore arm experienced.
parent states w/in hrs p/recvd vax; pt leg began to swell @ site of shot; swelled 3x size of fifty cents piece;
Employee c/o of itchy throat within 15 minutes of vaccine administration. Employee was observed a total of 45 minutes. After 45 minutes, states throat itchiness is gone. No other symptoms noted. Vital signs = BP 141/86, HR= 72, Puls Ox = 99%
swollen fingers in both of her hands; rash itched; numb fingers in both of her hands; rash all over her body; swollen lymph node in her left breast; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen fingers in both of her hands), RASH PRURITIC (rash itched), HYPOAESTHESIA (numb fingers in both of her hands), RASH (rash all over her body) and LYMPHADENOPATHY (swollen lymph node in her left breast) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swollen fingers in both of her hands), RASH PRURITIC (rash itched), HYPOAESTHESIA (numb fingers in both of her hands), RASH (rash all over her body) and LYMPHADENOPATHY (swollen lymph node in her left breast). At the time of the report, PERIPHERAL SWELLING (swollen fingers in both of her hands), RASH PRURITIC (rash itched), HYPOAESTHESIA (numb fingers in both of her hands), RASH (rash all over her body) and LYMPHADENOPATHY (swollen lymph node in her left breast) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No concomitant medications were reported.  No treatment medications were reported.
Patient received vaccine on Wednesday 9/15 felt very tired and laid in bed. Mom said she complained of itching and swelling under arm of vaccination site. Next day 9/17, patient had huge rash all over arm and upper body.   Presented to Pediatrician who believed it to be related to the injection. Extremely large, painful rash. Patient extremely lethargic. Missed 4 days of school.  Given 10ml of Diphenydramine every 6 hours and mupirocin 2% topical ointment.
fever 103.8, shaking chills, extreme fatigue, muscle aches, disorientation, skin extremely sensitive to touch
It started later in the day, in the afternoon, I felt extremely fatigued and a scratchy throat. It proceeded into a headache during that night. I may had had a dry cough, but it wasn't horrible. It wasn't constant either. I did not think too much of the extreme fatigue at first but how it hit me, I felt something really wrong. By the next day it lingered and by Sunday, I tested a home test and tested positive. I called my doctor and was told to go to a drive-in test center and was tested there and came positive. I was given PAXLOVID. I feel normal now.